CTLA4 and B-cell chronic lymphocytic leukemia: Consistently, we previously reported that CTLA-4 blocking antibody might be a beneficial form of immunotherapy for a subset of chronic lymphocytic leukemia (CLL) patients depending on the level of CTLA-4 expression on leukemic cells [23].